Galen Growth Asia is declaring War on Diabetes

The market for wearable medical devices is expected to skyrocket over the next few years. Whilst experiencing a long episode of exponential advancements in digital technologies, their costs have decreased considerably, not to say plummeted.

In a global cost-constrained healthcare industry, one could assume that this reduction in cost would be a real game changer. But is it really the case?  Revolutionising patient care at a distance, “connected health” and “e-health” technologies, provide cost efficient solutions to connect patients with healthcare professionals. The easy conclusion would be that delivering such healthcare solutions would carry no barrier to innovation and to investment. Still, few researches in Asia have been able to justify how investing in such technologies can provide sufficient return to claim to be the cure in a pressured healthcare market.

Read our latest handout DIABETES: A GLOBAL PROBLEM conducted by Holmusk and stay tuned for our latest research on Diabetes.

Latest News

Our Sponsors


Galen Growth News

Join our newsletter for updates in the world of HealthTech in Asia. More news are available under news


    January, 2017

Join our Partner Dubai 100 in their Global Healthcare Challenge 2017

We are proud to announce our partnership with the national pre-accelerator program of the United Ara...
    January 20, 2017
    Singapore | Facebook

Galen Growth Asia to showcase Asia’s HealthTech at Temasek’s Future of Healthcare session

Ageing populations, increased costs and more informed patients are redefining the demands on health...
    14 – 15 February

Galen Growth Asia is a proud supporting partner of the 4th annual edition of EmTech Asia

EMTECH Asia 2017, will host the 4th annual edition of EmTech Asia on 14 – 15 February, 2017 at...